1569-16-0, Catalysts function by providing an alternate reaction mechanism that has a lower activation energy than would be found in the absence of the catalyst. In some cases, the catalyzed mechanism may include additional steps.In a article, 1569-16-0, molcular formula is C9H8N2, introducing its new discovery.
BRISTOL-MYERS SQUIBB COMPANY; YE, Xiang-Yang; MORALES, Christian L.; HIGGINS, Mendi A.; MULL, Eric
The present invention provides compounds of Formula (Ia) or (Ib): or stereoisomers, tautomers, or pharmaceutically acceptable salts or solvates thereof, wherein all the variables are as defined herein. These compounds are antagonists to alphaV- containing integrins. This invention also relates to pharmaceutical compositions comprising these compounds and methods of treating a disease, disorder, or condition associated with dysregulation of alphaV-containing integrins, such as pathological fibrosis, transplant rejection, cancer, osteoporosis, and inflammatory disorders, by using the compounds and pharmaceutical compositions.
Because enzymes can increase reaction rates by enormous factors and tend to be very specific, 1569-16-0, typically producing only a single product in quantitative yield, they are the focus of active research.you can also check out more blogs about 1569-16-0
Reference£º
1,332-Naphthyridine – Wikipedia,
1,8-Naphthyridine | C8H6N326 – PubChem